Lv7
4790 积分 2022-12-02 加入
A new alternative: inhibiting complement activation in patients with IgA nephropathy
29天前
已完结
Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy
29天前
已关闭
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
1个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
1个月前
已完结
The role of complement in IgA nephropathy
1个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
1个月前
已完结
Drugs in Development to Treat IgA Nephropathy
1个月前
已完结
Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen
1个月前
已完结
With complements: C3 inhibition in the clinic
1个月前
已完结
皖公网安备34019202002308
